Tenet Healthcare (THC) to Release Quarterly Earnings on Tuesday

Tenet Healthcare (NYSE:THC - Get Free Report) is projected to announce its Q2 2025 earnings results before the market opens on Tuesday, July 22nd. Analysts expect Tenet Healthcare to post earnings of $2.84 per share and revenue of $5.16 billion for the quarter. Tenet Healthcare has set its FY 2025 guidance at 11.990-13.120 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, beating analysts' consensus estimates of $3.11 by $1.25. Tenet Healthcare had a return on equity of 22.58% and a net margin of 7.09%. The firm had revenue of $5.22 billion for the quarter, compared to analysts' expectations of $5.15 billion. During the same quarter in the prior year, the firm earned $3.22 EPS. The business's revenue for the quarter was down 2.5% compared to the same quarter last year. On average, analysts expect Tenet Healthcare to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.

Tenet Healthcare Stock Performance

Shares of NYSE THC traded up $1.86 during trading on Friday, reaching $177.00. 809,273 shares of the stock traded hands, compared to its average volume of 1,537,239. Tenet Healthcare has a 52-week low of $109.82 and a 52-week high of $179.91. The company has a debt-to-equity ratio of 2.23, a current ratio of 1.78 and a quick ratio of 1.70. The company has a 50-day moving average of $167.89 and a 200-day moving average of $143.75. The stock has a market capitalization of $16.44 billion, a P/E ratio of 11.71, a price-to-earnings-growth ratio of 1.26 and a beta of 1.64.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,001 shares of the company's stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $148.50, for a total transaction of $742,648.50. Following the sale, the director directly owned 22,377 shares in the company, valued at $3,322,984.50. This represents a 18.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Thomas W. Arnst sold 9,786 shares of the company's stock in a transaction that occurred on Wednesday, May 21st. The shares were sold at an average price of $166.00, for a total value of $1,624,476.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 54,121 shares of company stock valued at $8,846,305. 0.81% of the stock is owned by corporate insiders.

Institutional Trading of Tenet Healthcare

A hedge fund recently raised its stake in Tenet Healthcare stock. Jones Financial Companies Lllp grew its stake in Tenet Healthcare Corporation (NYSE:THC - Free Report) by 299.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,700 shares of the company's stock after acquiring an additional 1,274 shares during the quarter. Jones Financial Companies Lllp's holdings in Tenet Healthcare were worth $229,000 at the end of the most recent quarter. 95.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on THC shares. Morgan Stanley boosted their target price on Tenet Healthcare from $175.00 to $210.00 and gave the stock an "overweight" rating in a report on Monday, June 9th. The Goldman Sachs Group boosted their price target on Tenet Healthcare from $134.00 to $154.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. Robert W. Baird restated a "neutral" rating and issued a $137.00 price target (down previously from $153.00) on shares of Tenet Healthcare in a research note on Tuesday, April 15th. Royal Bank Of Canada boosted their price target on Tenet Healthcare from $183.00 to $189.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. Finally, Wall Street Zen upgraded Tenet Healthcare from a "hold" rating to a "buy" rating in a research report on Sunday, June 15th. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $185.41.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.